{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:40:03Z","timestamp":1726879203364},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Host factors such as angiotensin-converting enzyme 2 (ACE2) and the transmembrane protease, serine-subtype-2 (TMPRSS2) are important factors for SARS-CoV-2 infection. Clinical and pre-clinical studies demonstrated that RAAS-blocking agents can be safely used during a SARS-CoV-2 infection but it is unknown if DPP-4 inhibitors or SGLT2-blockers may promote COVID-19 by increasing the host viral entry enzymes ACE2 and TMPRSS2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated telmisartan, linagliptin and empagliflozin induced effects on renal and cardiac expression of ACE2, TMPRSS2 and key enzymes involved in RAAS (REN, AGTR2, AGT) under high-salt conditions in a non-diabetic experimental 5\/6 nephrectomy (5\/6 Nx) model. In the present study, the gene expression of<jats:italic>Ace2<\/jats:italic>,<jats:italic>Tmprss2<\/jats:italic>,<jats:italic>Ren<\/jats:italic>,<jats:italic>Agtr2<\/jats:italic>and<jats:italic>Agt<\/jats:italic>was assessed with qRT-PCR and the protein expression of ACE2 and TMPRSS2 with immunohistochemistry in the following experimental groups: Sham\u2009+\u2009normal diet (ND)\u2009+\u2009placebo (PBO); 5\/6Nx\u2009+\u2009ND\u2009+\u2009PBO; 5\/6Nx\u2009+\u2009high salt-diet (HSD)\u2009+\u2009PBO; 5\/6Nx\u2009+\u2009HSD\u2009+\u2009telmisartan; 5\/6Nx\u2009+\u2009HSD\u2009+\u2009linagliptin; 5\/6Nx\u2009+\u2009HSD\u2009+\u2009empagliflozin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the kidney, the expression of<jats:italic>Ace2<\/jats:italic>was not altered on mRNA level under disease and treatment conditions. The renal TMPRSS2 levels (mRNA and protein) were not affected, whereas the cardiac level was significantly increased in 5\/6Nx rats. Intriguingly, the elevated TMPRSS2 protein expression in the heart was significantly normalized after treatment with telmisartan, linagliptin and empagliflozin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study indicated that there is no upregulation regarding host factors potentially promoting SARS-CoV-2 virus entry into host cells when the SGLT2-blocker empagliflozin, telmisartan and the DPP4-inhibitor blocker linagliptin are used. The results obtained in a preclinical, experimental non-diabetic kidney failure model need confirmation in ongoing interventional clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-022-02747-1","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T10:34:12Z","timestamp":1648204452000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5\/6 nephrectomy\u2014effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker"],"prefix":"10.1186","volume":"23","author":[{"given":"Yingquan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Delic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard K.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianghong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthold","family":"Hocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"issue":"6","key":"2747_CR1","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1111\/bcp.14660","volume":"87","author":"C Chu","year":"2021","unstructured":"Chu C, Zeng S, Hasan AA, Hocher CF, Kramer BK, Hocher B. Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: Systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(6):2475\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"2747_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fphar.2020.01161","volume":"11","author":"I Valencia","year":"2020","unstructured":"Valencia I, Peiro C, Lorenzo O, Sanchez-Ferrer CF, Eckel J, Romacho T. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Front Pharmacol. 2020;11:1161.","journal-title":"Front Pharmacol"},{"key":"2747_CR3","doi-asserted-by":"publisher","first-page":"603736","DOI":"10.3389\/fphar.2021.603736","volume":"12","author":"RP Rothlin","year":"2021","unstructured":"Rothlin RP, Duarte M, Pelorosso FG, Nicolosi L, Salgado MV, Vetulli HM, Spitzer E. Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials. Front Pharmacol. 2021;12:603736.","journal-title":"Front Pharmacol"},{"issue":"12","key":"2747_CR4","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1007\/s13300-020-00942-7","volume":"11","author":"D Patoulias","year":"2020","unstructured":"Patoulias D, Papadopoulos C, Katsimardou A, Toumpourleka M, Doumas M. Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions. Diabetes Ther. 2020;11(12):3003\u20135.","journal-title":"Diabetes Ther"},{"issue":"4","key":"2747_CR5","first-page":"787","volume":"4","author":"A Ribeiro-Oliveira Jr","year":"2008","unstructured":"Ribeiro-Oliveira A Jr, Nogueira AI, Pereira RM, Boas WW, Dos Santos RA. Simoes e Silva AC: The renin-angiotensin system and diabetes: an update. Vasc Health Risk Manag. 2008;4(4):787\u2013803.","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"2747_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","volume":"88","author":"A Heurich","year":"2014","unstructured":"Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014;88(2):1293\u2013307.","journal-title":"J Virol"},{"issue":"2","key":"2747_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280 e278.","journal-title":"Cell"},{"issue":"2","key":"2747_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/cr.2008.15","volume":"18","author":"H Wang","year":"2008","unstructured":"Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 2008;18(2):290\u2013301.","journal-title":"Cell Res"},{"issue":"3","key":"2747_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","volume":"6","author":"K Kuba","year":"2006","unstructured":"Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6(3):271\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"2747_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fcimb.2020.00340","volume":"10","author":"MV Delpino","year":"2020","unstructured":"Delpino MV, Quarleri J. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Front Cell Infect Microbiol. 2020;10:340.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2747_CR11","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1038\/s41467-020-18781-2","volume":"11","author":"SP Sajuthi","year":"2020","unstructured":"Sajuthi SP, DeFord P, Li Y, Jackson ND, Montgomery MT, Everman JL, Rios CL, Pruesse E, Nolin JD, Plender EG, et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun. 2020;11(1):5139.","journal-title":"Nat Commun"},{"issue":"6","key":"2747_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","volume":"116","author":"L Chen","year":"2020","unstructured":"Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097\u2013100.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"2747_CR13","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","volume":"64","author":"MR Deshotels","year":"2014","unstructured":"Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu CM. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension. 2014;64(6):1368\u201375.","journal-title":"Hypertension"},{"issue":"7440","key":"2747_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251\u20134.","journal-title":"Nature"},{"issue":"1","key":"2747_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020;9(1):601\u20134.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"2747_CR16","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","volume":"68","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC. Effects of renin-angiotensin system blockade on renal angiotensin-(1\u20137) forming enzymes and receptors. Kidney Int. 2005;68(5):2189\u201396.","journal-title":"Kidney Int"},{"issue":"11","key":"2747_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/CS20120162","volume":"123","author":"LJ Burchill","year":"2012","unstructured":"Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Clin Sci (Lond). 2012;123(11):649\u201358.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"2747_CR18","doi-asserted-by":"publisher","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","volume":"296","author":"MJ Soler","year":"2009","unstructured":"Soler MJ, Ye M, Wysocki J, William J, Lloveras J, Batlle D. Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am J Physiol Renal Physiol. 2009;296(2):F398-405.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2747_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/db20-0765","volume":"70","author":"SN Batchu","year":"2021","unstructured":"Batchu SN, Kaur H, Yerra VG, Advani SL, Kabir MG, Liu Y, Klein T, Advani A. Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19. Diabetes. 2021;70(3):759\u201371.","journal-title":"Diabetes"},{"issue":"9","key":"2747_CR20","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1681\/ASN.2020050667","volume":"31","author":"J Wysocki","year":"2020","unstructured":"Wysocki J, Lores E, Ye M, Soler MJ, Batlle D. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19. J Am Soc Nephrol. 2020;31(9):1941\u20133.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2747_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1159\/000321471","volume":"32","author":"J Varagic","year":"2010","unstructured":"Varagic J, Ahmad S, Brosnihan KB, Habibi J, Tilmon RD, Sowers JR, Ferrario CM. Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol. Am J Nephrol. 2010;32(6):557\u201366.","journal-title":"Am J Nephrol"},{"issue":"5","key":"2747_CR22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/ndt\/gfr600","volume":"27","author":"S Bernardi","year":"2012","unstructured":"Bernardi S, Toffoli B, Zennaro C, Tikellis C, Monticone S, Losurdo P, Bellini G, Thomas MC, Fallo F, Veglio F, et al. High-salt diet increases glomerular ACE\/ACE2 ratio leading to oxidative stress and kidney damage. Nephrol Dial Transplant. 2012;27(5):1793\u2013800.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"2747_CR23","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","volume":"123","author":"PG Reeves","year":"1993","unstructured":"Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123(11):1939\u201351.","journal-title":"J Nutr"},{"key":"2747_CR24","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1210\/en.2013-1096","volume":"vol. 154","author":"AR Aroor","year":"2013","unstructured":"Aroor AR, Sowers JR, Bender SB, Nistala R, Garro M, Mugerfeld I, Hayden MR, Johnson MS, Salam M, Whaley-Connell A, et al. Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats. Endocrinology. 2013;154:2501\u201313.","journal-title":"Endocrinology"},{"issue":"5","key":"2747_CR25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.kint.2016.01.016","volume":"89","author":"O Tsuprykov","year":"2016","unstructured":"Tsuprykov O, Ando R, Reichetzeder C, von Websky K, Antonenko V, Sharkovska Y, Chaykovska L, Rahnenfuhrer J, Hasan AA, Tammen H, et al. The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5\/6 nephrectomy. Kidney Int. 2016;89(5):1049\u201361.","journal-title":"Kidney Int"},{"issue":"6","key":"2747_CR26","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.kint.2019.01.010","volume":"95","author":"AA Hasan","year":"2019","unstructured":"Hasan AA, von Websky K, Reichetzeder C, Tsuprykov O, Gaballa MMS, Guo J, Zeng S, Delic D, Tammen H, Klein T, et al. Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5\/6 nephrectomy. Kidney Int. 2019;95(6):1373\u201388.","journal-title":"Kidney Int"},{"issue":"1","key":"2747_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jdermsci.2019.11.003","volume":"97","author":"D Delic","year":"2020","unstructured":"Delic D, Wolk K, Schmid R, Gabrielyan O, Christou D, Rieber K, Rolser M, Jakob I, Wiech F, Griesser M, et al. Integrated microRNA\/mRNA expression profiling of the skin of psoriasis patients. J Dermatol Sci. 2020;97(1):9\u201320.","journal-title":"J Dermatol Sci"},{"key":"2747_CR28","doi-asserted-by":"publisher","unstructured":"Zeng S, Delic D, Chu C, Xiong Y, Luo T, Chen X, Gaballa MMS, Xue Y, Chen X, Cao Y, Hasan AA, Stadermann K, Frankenreiter S, Yin L, Kr\u00e4mer BK, Klein T, Hocher B. Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5\/6 nephrectomised rats on high salt diet. Biomed Pharmacother. 2022;146:112606. https:\/\/doi.org\/10.1016\/j.biopha.2021.112606.\u00a0","DOI":"10.1016\/j.biopha.2021.112606"},{"issue":"2","key":"2747_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631\u20137.","journal-title":"J Pathol"},{"issue":"11","key":"2747_CR30","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1681\/ASN.2006050423","volume":"17","author":"M Ye","year":"2006","unstructured":"Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol. 2006;17(11):3067\u201375.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2747_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","volume":"41","author":"C Tikellis","year":"2003","unstructured":"Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension. 2003;41(3):392\u20137 Dallas, Tex\u202f: 1979.","journal-title":"Hypertension"},{"issue":"2","key":"2747_CR32","doi-asserted-by":"publisher","first-page":"F353","DOI":"10.1152\/ajprenal.00144.2004","volume":"288","author":"N Li","year":"2005","unstructured":"Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1\u20137 by rat proximal tubules. Am J Physiol Renal Physiol. 2005;288(2):F353-362.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2747_CR33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/ATVBAHA.120.315229","volume":"41","author":"A Sakamoto","year":"2021","unstructured":"Sakamoto A, Kawakami R, Kawai K, Gianatti A, Pellegrini D, Kutys R, Guo L, Mori M, Cornelissen A, Sato Y, et al. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart. Arterioscler Thromb Vasc Biol. 2021;41(1):542\u20134.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2747_CR34","doi-asserted-by":"publisher","first-page":"664868","DOI":"10.3389\/fcell.2021.664868","volume":"9","author":"Z Chen","year":"2021","unstructured":"Chen Z, Hu J, Liu L, Chen R, Wang M, Xiong M, Li ZQ, Zhao Y, Li H, Guan C, et al. SARS-CoV-2 Causes Acute Kidney Injury by Directly Infecting Renal Tubules. Front Cell Dev Biol. 2021;9:664868.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2747_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10557-015-6592-7","volume":"29","author":"LH Zhang","year":"2015","unstructured":"Zhang LH, Pang XF, Bai F, Wang NP, Shah AI, McKallip RJ, Li XW, Wang X, Zhao ZQ. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1\/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart. Cardiovasc Drugs Ther. 2015;29(3):243\u201355.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"2747_CR36","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2337\/db06-0033","volume":"55","author":"J Wysocki","year":"2006","unstructured":"Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D. ACE and ACE2 activity in diabetic mice. Diabetes. 2006;55(7):2132\u20139.","journal-title":"Diabetes"},{"issue":"12","key":"2747_CR37","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2337\/db20-0669","volume":"69","author":"SRA Wijnant","year":"2020","unstructured":"Wijnant SRA, Jacobs M, Van Eeckhoutte HP, Lapauw B, Joos GF, Bracke KR, Brusselle GG. Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes. Diabetes. 2020;69(12):2691\u20139.","journal-title":"Diabetes"},{"issue":"5","key":"2747_CR38","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/HYPERTENSIONAHA.120.15948","volume":"76","author":"MA Sparks","year":"2020","unstructured":"Sparks MA, South AM, Badley AD, Baker-Smith CM, Batlle D, Bozkurt B, Cattaneo R, Crowley SD, Dell\u2019Italia LJ, Ford AL, et al. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension. 2020;76(5):1350\u201367 Dallas, Tex\u202f: 1979.","journal-title":"Hypertension"},{"issue":"4","key":"2747_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ncrna.2020.09.001","volume":"5","author":"A Widiasta","year":"2020","unstructured":"Widiasta A, Sribudiani Y, Nugrahapraja H, Hilmanto D, Sekarwana N, Rachmadi D. Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy. Noncoding RNA Res. 2020;5(4):153\u201366.","journal-title":"Noncoding RNA Res"},{"issue":"6","key":"2747_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ndt\/gfaa093","volume":"35","author":"V Palau","year":"2020","unstructured":"Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071\u20132.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2747_CR41","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1681\/ASN.2020040419","volume":"31","author":"D Batlle","year":"2020","unstructured":"Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, Swaminathan S. Covid, Ace2 in Cardiovascular L, Kidney Working G: Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. J Am Soc Nephrol. 2020;31(7):1380\u20133.","journal-title":"J Am Soc Nephrol"},{"key":"2747_CR42","doi-asserted-by":"publisher","first-page":"110678","DOI":"10.1016\/j.biopha.2020.110678","volume":"131","author":"M Dong","year":"2020","unstructured":"Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother. 2020;131:110678.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2747_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/ijerph18010284","volume":"18","author":"J Qi","year":"2021","unstructured":"Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, Zhao Z, Jin S. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection. Int J Environ Res Public Health. 2021;18(1):284.","journal-title":"Int J Environ Res Public Health"},{"issue":"5 Pt 2","key":"2747_CR44","first-page":"F776","volume":"270","author":"JE Tank","year":"1996","unstructured":"Tank JE, Moe OW, Star RA, Henrich WL. Differential regulation of rat glomerular and proximal tubular renin mRNA following uninephrectomy. Am J Physiol. 1996;270(5 Pt 2):F776-783.","journal-title":"Am J Physiol"},{"issue":"1","key":"2747_CR45","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1038\/s41598-020-60336-4","volume":"10","author":"D Delic","year":"2020","unstructured":"Delic D, Wiech F, Urquhart R, Gabrielyan O, Rieber K, Rolser M, Tsuprykov O, Hasan AA, Kramer BK, Baum P, et al. Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5\/6 nephrectomy. Sci Rep. 2020;10(1):3373.","journal-title":"Sci Rep"},{"issue":"1","key":"2747_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ejhf.2066","volume":"23","author":"EM Boorsma","year":"2021","unstructured":"Boorsma EM, Beusekamp JC, Ter Maaten JM, Figarska SM, Danser AHJ, van Veldhuisen DJ, van der Meer P, Heerspink HJL, Damman K, Voors AA. Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure. Eur J Heart Fail. 2021;23(1):68\u201378.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"2747_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9440(10)65139-5","volume":"155","author":"RE Gilbert","year":"1999","unstructured":"Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson-Berka JL, Johnston CI, Cooper ME. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol. 1999;155(2):429\u201340.","journal-title":"Am J Pathol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:18:34Z","timestamp":1726877914000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02747-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiment was approved by laboratory animal ethics committee (20170904092822, Jinan University, Guangzhou, China) and performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no.85\u201323, revised 1996); and in compliance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines, the Basel Declaration. Animals were euthanized according to the guidelines of the American Veterinary Medical Association (AVMA) Panel for euthanasia of animals (Ver. 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Denis Delic and Thomas Klein are employed by Boehringer Ingelheim Pharma GmbH & Co. KG. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}